Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone

@article{Engel2007DrugIC,
  title={Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone},
  author={J. Engel and A. Schally},
  journal={Nature Clinical Practice Endocrinology \&Metabolism},
  year={2007},
  volume={3},
  pages={157-167}
}
  • J. Engel, A. Schally
  • Published 2007
  • Medicine
  • Nature Clinical Practice Endocrinology &Metabolism
This article reviews the clinical uses of agonists and antagonists of luteinizing-hormone-releasing hormone (LHRH), also known as gonadotropin-releasing hormone. In particular, the state of the art treatment of breast, ovarian and prostate cancer, reproductive disorders, uterine leiomyoma, endometriosis and benign prostatic hypertrophy is reported. Clinical applications of LHRH agonists are based on gradual downregulation of pituitary receptors for LHRH, which leads to inhibition of the… Expand
Agonists of luteinizing hormone-releasing hormone in prostate cancer
Gonadotropin-releasing hormone antagonist: A real advantage?
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
Overview of elagolix for the treatment of endometriosis
The role of gonadotropin releasing hormone in normal and pathologic endocrine processes
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 89 REFERENCES
Hypothalamic Hormones and Cancer
...
1
2
3
4
5
...